Answers are grounded in this paper and cite their sources.
Dapagliflozin significantly improved treatment satisfaction among patients with type 2 diabetes mellitus for 14 weeks. Body weight loss significantly correlated with treatment satisfaction.Trial registration UMIN-CTR: UMIN000016304.
No takes yet. Share an insight, caveat, or question.
Nakajima et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: